wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38956448-A1AEFD33-26CA-46F0-B212-EBF0CF80E3E7
Q38956448-A1AEFD33-26CA-46F0-B212-EBF0CF80E3E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38956448-A1AEFD33-26CA-46F0-B212-EBF0CF80E3E7
A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.
P2860
Q38956448-A1AEFD33-26CA-46F0-B212-EBF0CF80E3E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38956448-A1AEFD33-26CA-46F0-B212-EBF0CF80E3E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7069b8e9cce65ab06a831fd2800dd2386720168e
P2860
ALK inhibitors in non-small cell lung cancer: crizotinib and beyond.